Filip Janku

Chief Medical Officer, Monte Rosa Therapeutics.

Companies

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Jun 30, 2026Sold 5,407 shares at $24.50 of Monte Rosa Therapeutics²
Jun 30, 2026Exercised options 5,407 shares at $13.41 of Monte Rosa Therapeutics²
Jun 29, 2026Sold 6,000 shares at $22.95 of Monte Rosa Therapeutics³
Jun 29, 2026Exercised options 6,000 shares at $7.56 of Monte Rosa Therapeutics³
Jun 24, 2026Sold 30,000 shares at $21.42 of Monte Rosa Therapeutics⁴
Jun 24, 2026Exercised options 30,000 shares at $7.56 of Monte Rosa Therapeutics⁴
Jun 23, 2026Sold 11,845 shares at $20.22 of Monte Rosa Therapeutics⁴
Jun 23, 2026Exercised options 6,000 shares at $7.56 of Monte Rosa Therapeutics⁴
Feb 23, 2026Sold 9,189 shares at $19.50 of Monte Rosa Therapeutics⁵
Jan 5, 2026Sold 3,155 shares at $15.17 of Monte Rosa Therapeutics⁶
Jan 2, 2026Granted 31,000 shares of Monte Rosa Therapeutics⁶
Jan 2, 2025Granted 36,000 shares of Monte Rosa Therapeutics⁷

The numbers on this page point here. Each one links to the record it came from.